BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34287276)

  • 21. CD8+ mycosis fungoides clinically masquerading as alopecia areata.
    Amin SM; Tan T; Guitart J; Colavincenzo M; Gerami P; Yazdan P
    J Cutan Pathol; 2016 Dec; 43(12):1179-1182. PubMed ID: 27546732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Erythrodermic CD4/CD8 Double-Negative Mycosis Fungoides: A Case Report.
    Alnasser MA; AlKhawajah NM; AlQadri NG; Shadid AM; Alsaif FM
    Case Rep Oncol; 2021; 14(1):256-261. PubMed ID: 33776713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypopigmented mycosis fungoides: report of five cases with ultrastructural observations.
    Breathnach SM; McKee PH; Smith NP
    Br J Dermatol; 1982 Jun; 106(6):643-9. PubMed ID: 6177331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical presentation, immunopathology, and treatment of juvenile-onset mycosis fungoides: a case series of 34 patients.
    Boulos S; Vaid R; Aladily TN; Ivan DS; Talpur R; Duvic M
    J Am Acad Dermatol; 2014 Dec; 71(6):1117-26. PubMed ID: 25264240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperpigmented mycosis fungoides: an unusual variant of cutaneous T-cell lymphoma with a frequent CD8+ phenotype.
    Pavlovsky L; Mimouni D; Amitay-Laish I; Feinmesser M; David M; Hodak E
    J Am Acad Dermatol; 2012 Jul; 67(1):69-75. PubMed ID: 21982059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypopigmented Mycosis Fungoides: Loss of Pigmentation Reflects Antitumor Immune Response in Young Patients.
    Martínez Villarreal A; Gantchev J; Lagacé F; Barolet A; Sasseville D; Ødum N; Charli-Joseph YV; Hernández Salazar A; Litvinov IV
    Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32707930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammatory vitiligo-like macules that simulate hypopigmented mycosis fungoides.
    Petit T; Cribier B; Bagot M; Wechsler J
    Eur J Dermatol; 2003; 13(4):410-2. PubMed ID: 12948929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological spectrum of mycosis fungoides type cutaneous T-cell lymphoma.
    Shaikh ZI; Rahman SB
    J Coll Physicians Surg Pak; 2006 Mar; 16(3):171-4. PubMed ID: 16542594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
    Ni X; Hazarika P; Zhang C; Talpur R; Duvic M
    Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Keratoderma-like T cell dyscrasia: A report of 13 cases and its distinction from mycosis fungoides palmaris et plantaris.
    Magro CM; Nguyen GH
    Indian J Dermatol Venereol Leprol; 2016; 82(4):395-403. PubMed ID: 27279297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.
    Bosisio FM; Cerroni L
    Am J Dermatopathol; 2015 Feb; 37(2):115-21. PubMed ID: 25406852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypopigmented Interface T-Cell Dyscrasia and Hypopigmented Mycosis Fungoides: A Comparative Study.
    Youssef R; Mahgoub D; Zeid OA; Abdel-Halim DM; El-Hawary M; Hussein MF; Morcos MA; Aboelfadl DM; Abdelkader HA; Abdel-Galeil Y; Abdel-Halim MRE
    Am J Dermatopathol; 2018 Oct; 40(10):727-735. PubMed ID: 30188378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperpigmented Mycosis Fungoides - A Rare Entity.
    Balić A; Jerković Gulin S; Čeović R; Ilić I; Radoš J
    Acta Dermatovenerol Croat; 2019 Jun; 27(2):131-132. PubMed ID: 31351512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypopigmented mycosis fungoides in childhood and adolescence: a long-term retrospective study.
    Castano E; Glick S; Wolgast L; Naeem R; Sunkara J; Elston D; Jacobson M
    J Cutan Pathol; 2013 Nov; 40(11):924-34. PubMed ID: 24320808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ichthyosiform mycosis fungoides: an atypical variant of cutaneous T-cell lymphoma.
    Hodak E; Amitay I; Feinmesser M; Aviram A; David M
    J Am Acad Dermatol; 2004 Mar; 50(3):368-74. PubMed ID: 14988677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency of hypopigmented mycosis fungoides in Egyptian patients presenting with hypopigmented lesions of the trunk.
    Abdel-Halim M; El-Nabarawy E; El Nemr R; Hassan AM
    Am J Dermatopathol; 2015 Nov; 37(11):834-40. PubMed ID: 26262921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Density of neoplastic lymphoid infiltrate, CD8+ T cells, and CD1a+ dendritic cells in mycosis fungoides.
    Goteri G; Filosa A; Mannello B; Stramazzotti D; Rupoli S; Leoni P; Fabris G
    J Clin Pathol; 2003 Jun; 56(6):453-8. PubMed ID: 12783973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of the phenotype on mycosis fungoides prognosis, a retrospective cohort study of 160 patients.
    Jaque A; Mereniuk A; Walsh S; Shear NH; Sade S; Zagorski B; Alhusayen R
    Int J Dermatol; 2019 Aug; 58(8):933-939. PubMed ID: 30761533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thymocyte selection-associated high-mobility group box as a potential diagnostic marker differentiating hypopigmented mycosis fungoides from early vitiligo: A pilot study.
    Ibrahim MA; Mohamed A; Soltan MY
    Indian J Dermatol Venereol Leprol; 2021; 87(6):819-825. PubMed ID: 31857520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.